04.03.2014 • NewsAgricultureBayerBiotechnology

Bayer Teams up with GreenLight on Sustainable Feedstocks

GreenLight Biosciences and Bayer CropScience have established a new partnership to explore applications of GreenLight's proprietary cell-free technologies to increase the productivity of potential manufacturing processes.

Financial terms of the agreement were not disclosed.

The Boston, Massachusetts-based biotech firm is developing ways of manufacturing crop protection products through bacteria, which have been engineered to produce enzymes for chemical synthesis processes.

CEO Andrey Zarur said his company wants "to be at the forefront of creating new, non-petroleum based processes. Specifically we aim to replace the use of fossil hydrocarbons and expensive natural precursors in the production of chemicals with sustainable feedstocks."

GreenLight said the "unique partnership" with Bayer "will couple the potential of our cell-free platform for efficient manufacturing with the "remarkable innovations" of the German chemical giant.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.